- Millennium Hotel Paris CDG, France
October 17 to 19, 2025 - +1-571-5561014
infectious@precisionglobalconferences.com
scientific Sessions
Viral hepatitis
Viral hepatitis, caused by infections with hepatitis viruses A, B, C, D, and E, remains a primary global health concern, leading to chronic liver disease, cirrhosis, and liver cancer. At the 2nd Edition of the Infectious Diseases World Conference, discussions focused on the effectiveness of vaccines for hepatitis A and B, progress in antiviral therapies for hepatitis C, and continued initiatives to combat hepatitis B and D by providing better alternatives for screening and treatment.
The conference also emphasized the need for global initiatives to increase awareness, ensure access to care, and reduce the burden of viral hepatitis, especially in regions with high infection rates.
Key Points:
- Types of Hepatitis: Caused by hepatitis A, B, C, D, and E viruses.
- Advancements: Progress in antiviral treatments, especially for hepatitis C.
- Vaccines: effective vaccines for hepatitis A and B, with ongoing efforts for others.
- Screening and Treatment: Improved access to screening and treatments for hepatitis B and D.
- Global Initiatives: Focus on awareness campaigns, access to care, and reducing infection rates, particularly in high-prevalence regions.
Related Sessions
Don't miss our future updates!